|
|
Article: Glaxo Dermatology Products announces the availability of ACLOVATE Cream and Ointment, 0.05%.
- Article from:
- PR Newswire
- Article date:
- January 20, 1987
CopyrightCOPYRIGHT 1987 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
RESEARCH TRIANGLE PARK, N.C., Jan. 19 /PRNewswire/ -- Glaxo Dermatology Products announces the availability of ACLOVATE(tm) (alclometasone dipropionate) Cream, 0.05 percent, and Ointment, 0.05 percent. Aclovate is a new non-fluorinated, low-to-mid potency topical corticosteroid for relief of inflammation and itching caused by dermatoses such as eczema and psoriasis.
According to Robert Vann, M.D., vice president for Medical Affairs at Glaxo, "Aclovate demonstrates the efficacy approaching that of a mid-potency topical corticosteroid while possessing the safety profile of 1.0 percent hydrocortisone."
Due to its excellent safety profile, Aclovate ...
Related newspaper, magazine, and journal articles:
|
|
Article: Aero Pharm Acquires Baker Cummins(TM) Dermatology ...
PR Newswire;
October 11, 2006 ;
634 words
... ... over-the-counter (OTC) dermatology products as well as U.S. rights to additional dermatology products from IVAX Laboratories, Inc ... the Baker Cummins(TM) OTC dermatology products, which include P&S ...
|
|